Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Glucose homeostasis in statin users-The LIFESTAT study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Education programmes for persons with type 1 diabetes using an insulin pump: A systematic review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Glucagon for hypoglycaemia treatment in type 1 diabetes

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Treatment of modifiable risk factors for foot ulceration in persons with diabetes: a systematic review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update)

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Oral insulin does not alter gut microbiota composition of NOD mice

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Effects of endogenous GIP in patients with type 2 diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The training induced increase in whole-body peak fat oxidation rate may be attenuated with aging

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Mitochondrial dysfunction in adults after out-of-hospital cardiac arrest

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Thomas Morville
  • Tine Dohlmann
  • Anja B Kuhlman
  • Tine Monberg
  • Mimmi Torp
  • Bolette Hartmann
  • Jens J Holst
  • Steen Larsen
  • Jørn W Helge
  • Flemming Dela
Vis graf over relationer

BACKGROUND: Statins are widely used to lower cholesterol concentrations in both primary and secondary prevention of cardiovascular disease. The treatment increases the risk of muscle pain (myalgia) and of type 2 diabetes. However, the underlying mechanisms remain disputed.

METHODS: We investigated whether statin induced myalgia is coupled to impaired glucose homeostasis using oral glucose tolerance test (OGTT), intravenous glucose tolerance test (IVGTT), and the hyperinsulinemic euglycemic clamp. We performed a cross-sectional study of statin users without CVD (primary prevention) stratified into a statin myalgic (M; n = 25) and a non-myalgic (NM; n = 39) group as well as a control group (C; n = 20) consisting of non-statin users.

RESULTS: A reduction in the insulin secretion rate during the OGTT was observed in the myalgic group compared with the non-myalgic group (AUC ISROGTT , C: 1032 (683 - 1500); M: 922 (678 - 1091); NM: 1089 (933 - 1391) pmol·L-1 ·min (median with 25%-75% percentiles), but no other measurements indicated impaired β-cell function. We found no other differences between the three groups for other measurements in the OGTT, IVGTT, and euglycemic clamp. Muscle protein content of GLUT4 and hexokinase II was similar between the three groups.

CONCLUSIONS: We conclude that statin users in primary prevention experiencing myalgia do not have impaired glucose homeostasis compared with other statin users or non-users. We consider this an important aspect in the dialogue between physician and patient regarding statin treatment and adverse effects.

OriginalsprogEngelsk
TidsskriftDiabetes - Metabolism: Research and Reviews (Print Edition)
Vol/bind35
Udgave nummer3
Sider (fra-til)e3110
ISSN1520-7552
DOI
StatusUdgivet - mar. 2019

Bibliografisk note

© 2018 John Wiley & Sons, Ltd.

ID: 59410901